Patient Outcomes in KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE): Systematic Literature Review

Understanding Lived Experiences with KCNQ2-Developmental and Epileptic Encephalopathy (KCNQ2-DEE)

Safety, Tolerability, and Pharmacokinetics of BHV-2100, a First-in-Class TRPM3 Antagonist for Pain

BHV-7000, A Novel, Selective Kv7.2/7.3 Potassium Channel Activator, Demonstrates Dose-Dependent Pharmacodynamic Effects on EEG Parameters in Healthy Adults